Abstract
The concentration of intracellular free Ca2+ ( [Ca2+]i) in human blood platelets was measured by use of the fluorescent probe quin-2. 5-Hydroxytryptamine (5-HT) caused a rapid increase of [Ca2+]i in the presence or absence of Ca2+ in the medium. The [Ca2+]i-rise was less marked in the absence of Ca2+ and could be antagonized by 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate-hydrochloride (TMB-8), an inhibitor of calcium release from internal stores. 5-HT induced a shape change reaction in the presence or absence of extracellular Ca2+, but the pEC50 of 5-HT was slightly higher in the presence of the cation. Shape change reaction and [Ca2+]i-rise showed similar time courses. Various 5-HT-agonists caused a rise of [Ca2+]i, whereas 5-HT-antagonists, but not the 5-HT-uptake inhibitor desmethylimipramine and the alpha 2-adrenoceptor antagonist yohimbine, counteracted the 5-HT-induced rise of the cation in a stereospecific manner. The antagonists were more potent than the agonists. The orders of potencies of the drugs affecting [Ca2+]i and platelet shape were similar. It is concluded that stimulation of 5-HT2-receptors of platelets causes a rapid release of intracellular calcium which, by activation of the contractile system, mediates the shape change reaction.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Affolter H., Erne P., Bürgisser E., Pletscher A. Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets. Naunyn Schmiedebergs Arch Pharmacol. 1984 Apr;325(4):337–342. doi: 10.1007/BF00504378. [DOI] [PubMed] [Google Scholar]
- Born G. V., Dearnley R., Foulks J. G., Sharp D. E. Quantification of the morphological reaction of platelets to aggregating agents and of its reversal by aggregation inhibitors. J Physiol. 1978 Jul;280:193–212. doi: 10.1113/jphysiol.1978.sp012380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graf M., Pletscher A. Shape change of blood platelets--a model for cerebral 5-hydroxytryptamine receptors? Br J Pharmacol. 1979 Apr;65(4):601–608. doi: 10.1111/j.1476-5381.1979.tb07870.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laubscher A., Pletscher A. Shape change and uptake of 5-hydroxytryptamine in human blood platelets: action of neuropsychotropic drugs. Life Sci. 1979 May 14;24(20):1833–1840. doi: 10.1016/0024-3205(79)90233-9. [DOI] [PubMed] [Google Scholar]
- Malagodi M. H., Chiou C. Y. Pharmacological evaluation of a new Ca++ antagonist, 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride (TMB-8): studies in skeletal muscles. Pharmacology. 1974;12(1):20–31. doi: 10.1159/000136517. [DOI] [PubMed] [Google Scholar]
- Peroutka S. J., Snyder S. H. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol. 1979 Nov;16(3):687–699. [PubMed] [Google Scholar]
- Rink T. J., Smith S. W., Tsien R. Y. Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca-independent activation for shape-change and secretion. FEBS Lett. 1982 Nov 1;148(1):21–26. doi: 10.1016/0014-5793(82)81234-9. [DOI] [PubMed] [Google Scholar]
- Tsien R. Y. A non-disruptive technique for loading calcium buffers and indicators into cells. Nature. 1981 Apr 9;290(5806):527–528. doi: 10.1038/290527a0. [DOI] [PubMed] [Google Scholar]
- Tsien R. Y., Pozzan T., Rink T. J. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J Cell Biol. 1982 Aug;94(2):325–334. doi: 10.1083/jcb.94.2.325. [DOI] [PMC free article] [PubMed] [Google Scholar]